Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fillenbaum, G.
Right arrow Articles by Weiman, A.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fillenbaum, G.
Right arrow Articles by Weiman, A.L.
Related Collections
Right arrow All Health Services Research
Right arrow Cost effectiveness/economic
Right arrow All Cognitive Disorders/Dementia
Right arrow Alzheimer's disease
Neurology 2001;56:201-206
© 2001 American Academy of Neurology


Articles

Use and cost of hospitalization of patients with AD by stage and living arrangement

CERAD XXI

G. Fillenbaum, PhD, A. Heyman, MD, B.L. Peterson, PhD, C.F. Pieper, DrPH; and A.L. Weiman, MA

From the Center for the Study of Aging and Human Development (Dr. Fillenbaum, A.L. Weiman), the Division of Neurology (Dr. Heyman), and the Division of Biometry (Drs. Peterson and Pieper), Duke University, Durham, NC.

Address correspondence and reprint requests to Dr. G. Fillenbaum, Box 3003, Duke University Medical Center, Durham, NC 27710.

OBJECTIVE: To determine the probability, frequency, length of stay, and Medicare costs of hospitalization of institutionalized and noninstitutionalized patients with AD at various stages of dementia.

METHODS: The authors analyzed the 1991 to 1995 Medicare records of 420 CERAD patients with AD, a group which, at entry, had no serious comorbidities. They were geographically distributed across the United States and observed for a median of 2.5 years. Repeated measures logistic regression and generalized estimating equations were used to model the probability of hospitalization. Among those hospitalized, the general linear mixed model was used to determine number of admissions, length of stay, and Medicare cost. Demographic characteristics and calendar date were controlled in all analyses.

RESULTS: As dementia worsened, the probability of hospitalization increased among patients living at home, but decreased among those who were institutionalized. Number of admissions, length of stay, and cost also decreased significantly as stage worsened among the institutionalized patients, but the stage of dementia had no effect in non-institutionalized patients.

CONCLUSION: The hospitalization experience of patients with AD living at home differs from that of patients with AD living in institutions. Residential setting appears to be an important determinant of hospitalization in patients with AD.




This article has been cited by other articles:


Home page
J Aging HealthHome page
F. W. Porell and M. Carter
Discretionary Hospitalization of Nursing Home Residents With and Without Alzheimer's Disease: A Multilevel Analysis
J Aging Health, April 1, 2005; 17(2): 207 - 238.
[Abstract] [PDF]


Home page
NeurologyHome page
G. Fillenbaum, A. Heyman, B.L. Peterson, C.F. Pieper, and A.L. Weiman
Use and cost of outpatient visits of AD patients: CERAD XXII
Neurology, June 26, 2001; 56(12): 1706 - 1711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.